You're reading the free version. Trader adds the live tape and alerts.
Start tracking
ENTA Disposition Disclosure
Rottinghaus Scott T. · SEC Form 4 · Filed Aug 10, 2026
Disposition
Calculated transaction value
$19.57K
Rottinghaus Scott T. Chief Medical Officer
ENTA
Transaction date
Aug 8, 2026
Public filing date
Aug 10, 2026
Filing lag
Filed 2 days later
ENTA daily price context
Close on/before transaction
$13.77
Aug 7, 2026
First close after public filing
$13.81
Aug 10, 2026
30-day return after filing
-4.13%
Through Sep 9, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 1,467 shares @ $13.34
- SEC ownership
- Direct
- Transaction code
- F
- Form
- 4
- Filing identifier
- 0002064832-26-000266
Filing cohort
Transactions in this filing
Showing 1 of 1
Trades
1
Issuers
1
Estimated value
$19.57K
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Enanta Pharmaceuticals Inc ENTA Current | Disposition | Aug 8, 2026 | $19.57K |